Is irrelevant cleavage the price of antisense efficacy?

被引:32
作者
Stein, CA
机构
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA
关键词
antisense oligonucleotides; RNase H; irrelevant cleavage; backbone modifications;
D O I
10.1016/S0163-7258(99)00053-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antisense oligonucleotides are useful reagents for the suppression of gene expression. Their mechanism of action in eukaryotic cells appears to depend heavily on the activity of RNase H, a ubiquitous enzyme that cleaves the mRNA strand of an RNA-DNA duplex. However, the stringency requirements of RNase H are very low, and as little as a 5-base complementary region of oligomer to target may be sufficient to elicit RNase H activity. This would result in scission of nontargeted mRNAs, or what is known as "irrelevant cleavage." One strategy to reduce RNase H competency that has been employed is modification of the oligonucleotide backbone, replacing phosphodiester linkages with uncharged methylphosphonates, which are not RNase H competent. Another strategy involves replacement of deoxyribonucleic acid with 2'-O-alkylribonucleic acid. A third strategy, eliminating RNase H dependency entirely, requires activation of RNase P. The relative merits of these strategies will be discussed in the context of selective inhibition of gene function. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 40 条
[1]   Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies [J].
Agrawal, S ;
Jiang, ZW ;
Zhao, QY ;
Shaw, D ;
Cai, QY ;
Roskey, A ;
Channavajjala, L ;
Saxinger, C ;
Zhang, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2620-2625
[3]   Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA [J].
Anderson, KP ;
Fox, MC ;
BrownDriver, V ;
Martin, MJ ;
Azad, RF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) :2004-2011
[4]   Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides [J].
Benimetskaya, L ;
Takle, GB ;
Vilenchik, M ;
Lebedeva, I ;
Miller, P ;
Stein, CA .
NUCLEIC ACIDS RESEARCH, 1998, 26 (23) :5310-5317
[5]  
Bennett CF, 1997, J PHARMACOL EXP THER, V280, P988
[6]   ENZYMATIC AMPLIFICATION OF TRANSLATION INHIBITION OF RABBIT BETA-GLOBIN MESSENGER-RNA MEDIATED BY ANTI-MESSENGER OLIGODEOXYNUCLEOTIDES COVALENTLY LINKED TO INTERCALATING AGENTS [J].
CAZENAVE, C ;
LOREAU, N ;
THUONG, NT ;
TOULME, JJ ;
HELENE, C .
NUCLEIC ACIDS RESEARCH, 1987, 15 (12) :4717-4736
[7]   TARGETED DEGRADATION OF MESSENGER-RNA IN XENOPUS OOCYTES AND EMBRYOS DIRECTED BY MODIFIED OLIGONUCLEOTIDES - STUDIES OF AN2 AND CYCLIN IN EMBRYOGENESIS [J].
DAGLE, JM ;
WALDER, JA ;
WEEKS, DL .
NUCLEIC ACIDS RESEARCH, 1990, 18 (16) :4751-4757
[8]  
DEAN N, 1996, J BIOL CHEM, V269, P16416
[9]   INHIBITION OF PROTEIN-KINASE C-ALPHA EXPRESSION IN MICE AFTER SYSTEMIC ADMINISTRATION OF PHOSPHOROTHIOATE ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
DEAN, NM ;
MCKAY, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11762-11766
[10]   INHIBITION OF HIGH-AFFINITY BASIC FIBROBLAST GROWTH-FACTOR BINDING BY OLIGONUCLEOTIDES [J].
FENNEWALD, SM ;
RANDO, RF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) :21718-21721